GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVG) » Definitions » Other Current Receivables

CSPC Pharmaceutical Group (FRA:CVG) Other Current Receivables : €597 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Other Current Receivables?

CSPC Pharmaceutical Group's Other Current Receivables for the quarter that ended in Dec. 2023 was €597 Mil.

CSPC Pharmaceutical Group's quarterly Other Current Receivables declined from Jun. 2023 (€531.47 Mil) to Sep. 2023 (€0.00 Mil) but then increased from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€596.52 Mil).

CSPC Pharmaceutical Group's annual Other Current Receivables declined from Dec. 2021 (€530.77 Mil) to Dec. 2022 (€486.30 Mil) but then increased from Dec. 2022 (€486.30 Mil) to Dec. 2023 (€596.52 Mil).


CSPC Pharmaceutical Group Other Current Receivables Historical Data

The historical data trend for CSPC Pharmaceutical Group's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Other Current Receivables Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 336.07 355.76 530.77 486.30 596.52

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 486.30 - 531.47 - 596.52

CSPC Pharmaceutical Group Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


CSPC Pharmaceutical Group Other Current Receivables Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (FRA:CVG) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (FRA:CVG) Headlines

From GuruFocus

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2009

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 05-05-2010

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-09-2010

A cheap dutch stock - Crown van Gelder

By batbeer2 batbeer2 01-09-2011

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-08-2010

WeissLaw LLP Investigates Convergys Corporation

By PRNewswire PRNewswire 06-30-2018

Convergys Corp. Reports Operating Results (10-K)

By gurufocus 10qk 02-25-2011

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-09-2010